Stephanie Okey Sells Crinetics Pharmaceuticals Stock

On June 17, 2026, Stephanie Okey, a director at Crinetics Pharmaceuticals, Inc. (CRNX), sold a total of 6,900 shares of common stock. The sales were executed through an automatic Rule 10b5-1 trading plan. The first transaction involved 6,292 shares sold at an average price of $35.62 per share, with prices ranging from $35.19 to $36.06. The second transaction involved 608 shares sold at an average price of $36.22 per share, with prices ranging from $36.19 to $36.29. Following these transactions, Ms. Okey directly owns 6,400 shares of common stock.